200 results on '"Giacopuzzi, Edoardo"'
Search Results
2. Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
3. CHARR efficiently estimates contamination from DNA sequencing data
4. Next Generation Sequencing Analysis in Early Onset Dementia Patients.
5. Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
6. Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
7. Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles
8. The effect of childhood trauma on blood transcriptome expression in major depressive disorder
9. Self-supervised learning for characterising histomorphological diversity and spatial RNA expression prediction across 23 human tissue types
10. CHARR efficiently estimates contamination from DNA sequencing data
11. Author Correction: A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
12. Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome
13. Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
14. A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
15. Genomic and biochemical characterization of sialic acid acetylesterase (siae) in zebrafish
16. Ehlers–Danlos syndrome with lethal cardiac valvular dystrophy in males carrying a novel splice mutation in FLNA
17. Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder.
18. The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing
19. Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder.
20. Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model
21. Editorial: Application of Omics Approaches to the Diagnosis of Genetic Neurological Disorders
22. Human sialic acid acetyl esterase: Towards a better understanding of a puzzling enzyme
23. Characterization of three sialidases from Danio rerio
24. Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
25. Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α
26. Additional file 1 of Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
27. Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
28. Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing.
29. Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent TUBB2A mutation.
30. GREEN-DB: a framework for the annotation and prioritization of non-coding regulatory variants from whole-genome sequencing data.
31. GREEN-DB: a framework for the annotation and prioritization of non-coding regulatory variants in whole-genome sequencing
32. Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
33. Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD)
34. Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma
35. Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
36. SA43ANALYSIS OF GENETIC AND ENVIRONMENTAL CONTRIBUTION TO ALTERED GENE EXPRESSION PROFILES OBSERVED IN MAJOR DEPRESSIVE DISORDER
37. SA49THE EFFECT OF CHILDHOOD TRAUMA ON BLOOD EXPRESSION OF MED22 IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IS MEDIATED BY CIS-ACTING SNPS
38. Clinical and molecular characterization of a 13-year-old Indian boy with cutis laxa type 2B: Identification of two novel PYCR1 mutations by amplicon-based semiconductor exome sequencing
39. Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
40. Genome-wide analysis of RNA-editing levels in human blood identified interactions with mRNA processing genes and suggested correlation with biological and drug-related variables
41. The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses
42. Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia
43. Real-world clinical applicability of pathogenicity predictors assessed onSERPINA1mutations in alpha-1-antitrypsin deficiency
44. GARFIELD-NGS: Genomic vARiants FIltering by dEep Learning moDels in NGS
45. Differential Enzymatic Activity of Rat ADAR2 Splicing Variants Is Due to Altered Capability to Interact with RNA in the Deaminase Domain
46. Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
47. Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity
48. Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways
49. GARFIELD-NGS: Genomic vARiants FIltering by dEep Learning moDels in NGS
50. Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.